about
Plant-based vaccines for animals and humans: recent advances in technology and clinical trialsClinical development of Ebola vaccinesHerpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspectiveSafety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adultsGroup B Streptococcus vaccine: state of the artRecent advances in the development of vaccines for tuberculosisRecent advances in immunotherapy and vaccine development for peanut allergyTherapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advancesLatest developments and future directions in dengue vaccinesRationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvantsPrevention of rare diseases: how revolutionary techniques can help vulnerable individuals-the example of serogroup B meningococcal infectionMulticomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United StatesEditorial.An outbreak of serogroup C (ST-11) meningococcal disease in Tijuana, Mexico.Vaccine against arteriosclerosis: an update.Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresisInfluenza vaccination and treatment in children with neurologic disorders.Vaccines against drugs of abuse: where are we now?Killed oral cholera vaccines: history, development and implementation challengesSuccesses and challenges in varicella vaccineLiposomes as vaccine delivery systems: a review of the recent advances.Early trends in invasive pneumococcal disease in children following the introduction of 13-valent pneumococcal conjugate vaccine: results from eight years of active surveillance in a Mexican hospital.Human papilloma virus vaccination: impact and recommendations across the world.Vaccine development and new attempts of treatment for ragweed allergy.Two or three primary dose regime for Haemophilus influenzae type b conjugate vaccine: meta-analysis of randomized controlled trialsNeisseria meningitidis and Streptococcus pneumoniae as leading causes of pediatric bacterial meningitis in nine Mexican hospitals following 3 years of active surveillance.Efficacy of varicella (VZV) vaccination: an update for the clinician.How to fight pertussis?The role of Human Papilloma Virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infectionAn update on vaccines against Shigella.Novel HIV vaccine strategies: overview and perspective.Influenza vaccination in children at high risk of respiratory disease.Working together: interactions between vaccine antigens and adjuvants.Auditory and visual hallucinations after influenza vaccine: a case reportAdvances and controversies in yellow fever vaccinationAdvances in immune-modulating therapies to treat atherosclerotic cardiovascular diseasesMHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines.The rationale of vectored gene-fusion vaccines against cancer: evolving strategies and latest evidence.Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1).A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
P1433
Q26775788-C7E93B4B-FEA1-424B-A4CF-4FCB598FFA5CQ26775792-51CD17E6-3FA4-498C-B4A4-4656F87B681AQ26781940-D462B1C9-6ADC-443D-B2A2-876358C8FD21Q26781949-78613F75-0BBC-4B0B-9E8F-851E9D9C6A1DQ26796438-5012C5C1-CD5F-48C7-8A70-D20A4DF0CC09Q26796440-96158881-059F-4D3B-982A-F37EA9CCDF7EQ26796442-7800C2D4-F339-4D18-B4A5-C503E0B4BD94Q26827475-C32ADE8D-3D67-4509-BB74-AE5A140B6966Q27023422-C7F6E1DC-D2BB-4725-9387-A01CD0676B83Q27025822-81B11FDC-6E79-45F8-ACF9-455117C5F834Q28080522-2C05F9D5-E950-4374-A071-3ACA1A101916Q30235072-B1AC0D3C-FFC3-4139-A595-0CAEECE3F726Q30413742-0EC5F442-6674-48EF-8DFB-75A48BBBACAAQ33415019-595DEC84-9FA3-4A85-AEA8-70323D303A4BQ33641227-5151D5A0-F6F1-4938-97E4-699ED4BC5890Q33641234-568E8E68-A70B-4959-85BA-4EA83EE5B664Q33776771-F66E7808-69C0-442A-8087-D8DE1451C213Q33776777-B08FCF17-FEB6-4580-83FF-2A4C91B39D55Q34087755-2CC61A14-6679-47AD-9950-FEA2E221C665Q34416710-12F3328E-F1DC-4C9D-8818-8060097E7724Q34418761-04014C79-C85A-4256-9E61-D3BE121C4427Q34418768-EA558299-AF4B-4DB5-A52F-977AC2A8A13EQ34704575-40534A67-42EB-4FBC-A3BD-1C017B817456Q35528924-75A78ECC-5D11-4190-AC43-8EF6CD5DCADBQ35528932-1C760EDF-21A0-4C14-B517-A82FA5958753Q37158216-B93CC9A0-9F6F-4008-9384-F3B4EB5F8263Q37158220-92D0B098-B9A3-428C-B99B-5743140B2A9AQ37668385-C345B07F-A305-4E74-8BB9-1BFACC2562E3Q37668390-3D59AE3D-BDD4-4F14-A247-8EF6F92D4E58Q37668395-378B508E-3797-4722-B9CA-3FDF0B9EDA36Q37668399-D33155A1-33E4-4BB1-9CD4-D99C0FFF20A9Q37668402-2C84A99A-564D-42C0-AD24-3CE65BB321EEQ37668409-678BA10D-7A3D-484E-A8B1-4216357EB275Q37698518-CC35CD64-ACA1-4A5C-B52D-977DB80BCDB5Q37709619-D9848AF0-C06A-49DF-9CCF-6493C2BF53D8Q37709623-3F29B171-5802-4991-84D1-A6FF2FE9731CQ37709626-23173E3E-6EFE-42F1-A82C-AA0AA467109AQ38206518-39EC7FC7-0892-4B9F-ACB8-91645090BF7EQ38206519-721E41F6-D9DB-4E7D-B085-166F58916BF3Q38206520-86FB0CE2-2D39-4E42-87D0-FCBB8666BEE5
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van SAGE Publications
@nl
wissenschaftliche Fachzeitschrift
@de
name
Therapeutic advances in vaccines
@ast
Therapeutic advances in vaccines
@en
Therapeutic advances in vaccines
@es
Therapeutic advances in vaccines
@it
Therapeutic advances in vaccines
@nl
type
label
Therapeutic advances in vaccines
@ast
Therapeutic advances in vaccines
@en
Therapeutic advances in vaccines
@es
Therapeutic advances in vaccines
@it
Therapeutic advances in vaccines
@nl
prefLabel
Therapeutic advances in vaccines
@ast
Therapeutic advances in vaccines
@en
Therapeutic advances in vaccines
@es
Therapeutic advances in vaccines
@it
Therapeutic advances in vaccines
@nl
P3181
P1055
P1156
21100777378